Home›Companies›Healthcare›Atrility Medical

Atrility Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 5, 2026·Suggest an edit

About Atrility Medical

Atrility Medical is a private company based in Madison, Wisconsin. It has reported $4,995,995 raised in four offerings on Form D since April 2018. Its chief executive is Sean McCormick.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 7, 2025Feb 5, 2026$1,000,000of $2.0M target3$333KDebt, OptionsRule 506(b)Form D ↗
Jun 15, 2022Jun 29, 2022$3,385,995of $3.8M target15$225KEquityRule 506(b)Form D ↗
Sep 18, 2020Oct 1, 2020$300,000of $700K target1$300KDebtRule 506(b)Form D ↗
Feb 1, 2018Apr 13, 2018$310,000of $500K target7$44,286DebtRule 506(b)Form D ↗
Total, four offerings$4,995,995

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Atrility Medical's Form D filed Feb 5, 2026.

SM
Sean McCormick
Chief Executive Officer and director
MP
Michael Partsch
Director
Also a director at AIQ Solutions and Gregor Diagnostics and an executive officer and director at Nalu Medical.

Earlier filings also listed Peter Lukszys (executive officer and promoter, last listed Jun 2022) and David Kaysen (president/ceo and director, last listed Jun 2022).

Sources

  1. SECAtrility Medical, Inc. filing history